Ayrshire Exits PepsiCo Position in Q2, Sells 36,000 Shares

Ayrshire Capital Management fully divested its 36,032-share PepsiCo (PEP) stake, valued at $4.76 million, during Q2 2025, as disclosed in a July 9 SEC filing. This exit represented 2.61% of Ayrshire's Q2 reportable assets under management and means the fund now holds zero PEP shares. The divestment occurs amidst PepsiCo's significant stock underperformance, down nearly 16% over the past year, and despite marginally beating Q2 estimates, its net income fell sharply due to impairments, reflecting persistent headwinds such as rising costs and sluggish demand.

Analysis

Ayrshire Capital Management has liquidated its entire PepsiCo (PEP) position, selling 36,032 shares valued at $4.76 million during Q2 2025. This divestment, which represented 2.61% of the fund's reportable assets, aligns with PepsiCo's significant fundamental and market challenges. The stock has underperformed the S&P 500 by over 29 percentage points in the past year, falling nearly 16% and trading 25.8% below its 52-week high as of July 10, 2025. This weakness is underpinned by operational headwinds, including rising costs and sluggish consumer demand, which led to just 2% organic revenue growth in 2024. The most recent Q2 2025 results, while marginally beating estimates, revealed a concerning 1% net sales growth and a sharp decline in net income to $1.2 billion from $3.0 billion year-over-year, primarily due to impairment charges on its Rockstar and Be & Cheery brands. While management reiterated a modest full-year outlook of low-single-digit revenue growth and flat EPS, and is pursuing portfolio diversification into healthier products, the core business faces decelerating growth. The stock's primary appeal remains its 4.09% dividend yield, stemming from 53 consecutive years of increases, which positions it as a holding for income-focused investors rather than those seeking capital appreciation.

Key Decisions for Investors

• Given Ayrshire's complete exit and PepsiCo's weak fundamentals, including just 1% sales growth and a sharp net income drop from impairments, growth-oriented investors should consider reducing exposure or avoiding new positions until there is clear evidence of a turnaround in organic revenue.
• For income-focused investors, the 4.09% dividend yield remains attractive, but they must monitor the stagnating earnings and top-line deceleration, as these could eventually threaten future dividend growth and capital preservation.
• Investors should closely watch the performance of management's strategic initiatives, such as the push into healthier products and the 'away-from-home' channel, as success in these areas is critical to reversing the current negative trajectory and justifying a long-term holding.